Will my insurance cover GLP-1 medications for weight loss
Safety and Tolerability As with many metabolic therapies, the most commonly reported side effects in the Retatrutide trial included gastrointestinal symptoms such as nausea, diarrhea, constipation, vomiting, and decreased appetite, patterns seen with many gut-hormone modulators
US Customs and Border Protection has increased scrutiny of peptide imports following FDA guidance changes regarding unapproved drug substances
doi: 10.1038/s41591-024-02996-7
By inhibiting alpha-glucosidase, alpha-glucosidase inhibitors slow the absorption of glucose from the gut, blunting the post-meal rise in blood glucose
Nothing in this article should be interpreted as medical advice or as promoting the treatment or prevention of disease